Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study to Assess Adverse Events and Change in Disease Activity of Intramuscular AGN-151586 Injection in Toxin-Naïve Adult Participants With Glabellar Lines

ClinicalTrials.gov ID: NCT05248880

Public ClinicalTrials.gov record NCT05248880. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 4:11 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Multicenter Study to Evaluate the Safety and Efficacy of AGN-151586 for the Treatment of Glabellar Lines in Toxin-Naïve Subjects

Study identification

NCT ID
NCT05248880
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AbbVie
Industry
Enrollment
309 participants

Conditions and interventions

Interventions

  • AGN-151586 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 7, 2022
Primary completion
Jan 31, 2023
Completion
Jan 31, 2023
Last update posted
Feb 17, 2026

2022 – 2023

United States locations

U.S. sites
12
U.S. states
11
U.S. cities
12
Facility City State ZIP Site status
Clear Dermatology & Aesthetics Center /ID# 238990 Scottsdale Arizona 85255-4134
Steve Yoelin MD Medical Associate Inc /ID# 243197 Newport Beach California 92663
Marcus Medical Spa /ID# 241703 Redondo Beach California 90277
DMR Research PLLC /ID# 239061 Westport Connecticut 06880
Duplicate_Kavali Plastic Surgery and Skin Renewal Center /ID# 244808 Atlanta Georgia 30328
DelRicht Research /ID# 244890 Baton Rouge Louisiana 70809
Maryland Dermatology Laser, Skin, & Vein Institute /ID# 239067 Hunt Valley Maryland 21030-3216
WDC Cosmetic and Research, PLLC /ID# 233935 Wilmington North Carolina 28405
Clinical Research Center of the Carolinas /ID# 239064 Charleston South Carolina 29407
Duplicate_Austin Institute for Clinical Research /ID# 238989 Pflugerville Texas 78660
Kalo Clinical Research /ID# 247279 West Valley City Utah 84120-2058
SkinDC /ID# 238988 Arlington Virginia 22209

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05248880, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 17, 2026 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05248880 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →